Tyra Biosciences

1 follower


Tyra Biosciences is targeting new pathways of acquired resistance in oncology with purpose-built drugs for the benefit of patients.

Employees

11-50

Links

Org chart

Todd Harris

Collapse
Ronald V. Swanson
Chief Scientific Officer
Robert L. Hudkins
Chief Technology Officer
Piyush Patel
Chief Development Officer
Ali Fawaz
General Counsel & Corporate Secretary
Sarah Honig
VP, Corporate Development & Strategy
Gary Price
VP of Quality
Michael Bober
VP, Clinical Development & Medical Affairs
Fernando Blanco
Senior Director, Clinical & Translational Scientist
George Melko
VP, Regulatory Affairs
Curt Dvorak
Senior Director of Medicinal Chemistry